Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma

Journal of Immunology

Volumn 166, Issue 3, 2001, Pages 2025-2032

  Drouin, S M ^a   Kildsgaard, J ^a   Haviland, J ^a   Zabner, J ^a   Jia, H P ^a   McCray P B , Jr ^a   Tack, B F ^a   Wetsel, R A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS MUCOSA; BRONCHUS MUSCLE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RECEPTOR BINDING; RESPIRATORY DISTRESS; SEPSIS; SMOOTH MUSCLE CONTRACTION; THROMBOCYTE AGGREGATION;

EID: 0035253577     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.3.2025     Document Type: Article

References (77)

1. Lung inflammation: Normal host defense or a complication of some diseases?
2. Molecular organization and function of the complement system
3. Biology of the complement system
4. Complement anaphylatoxins (C3a, C4a, C5a) and their receptors (C3aR, C5aR/CD88) as therapeutic targets in inflammation
5. Anaphylatoxins: Possible roles in disease
6. Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages
7. Prolonged elevation of intracellular cyclic AMP levels in U937 cells increases the number of receptors for and the responses to formylmethionyl-leucylphenylalanine, independently of the differentiation process
8. Activation of human neutrophils by C3a and C5A: Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst
9. C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins
10. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils
11. Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a
12. The degradation product of the C5a anaphylatoxin C5adesArg retains basophil-activating properties
13. A mechanism of action for anaphylatoxin C3a stimulation of mast cells
14. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells
15. Degranulation from human eosinophils stimulated with C3a and C5a
16. A comparison of C3a- and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo
17. C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: Epithelial and endothelial priming is required for C3a-induced eosinophil adhesion
18. Demonstration of a specific C3a receptor on guinea pig platelets
19. Regulation of B cell functions by C3a and C3a(desArg): Suppression of TNF-a, IL-6, and the polyclonal immune response
20. Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a(desArg)
21. Chemotaxis by mouse macrophage cell lines
22. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: Flow cytometric and chemotaxis studies
23. Human T cells express the C5a receptor and are chemoattracted to C5a
24. Histamine-induced inhibition of normal human basophil chemotaxis to C5a
25. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation
26. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway
27. C3a and C5a stimulate chemotaxis of human mast cells
28. The chemotactic receptor for human C5a anaphylatoxin
29. Molecular cloning and characterization of the human anaphylatoxin C3a receptor
30. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells
31. The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes
32. Evaluation of C3a receptor expression on human leukocytes by the use of novel monoclonal antibodies
33. Characterization of a receptor for C5a anaphylatoxin on human eosinophils
34. Differential expression of complement receptors on human basophils and mast cells: Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells
35. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1
36. Cultured human glomerular mesangial cells express the C5a receptor
37. Cellular expression of the C5a anaphylatoxin receptor (C5aR): Demonstration of C5aR on nonmyeloid cells of the liver and lung
38. 2+ release
39. Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells
40. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: Analysis in multiple sclerosis and bacterial meningitis
41. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia
42. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes
43. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system
44. A neuronal C5a receptor and an associated apoptotic signal transduction pathway
45. Human chemotaxis receptor genes cluster at 19q 13.3-13.4: Characterization of the human C5a receptor gene
46. The mouse anaphylatoxin C3a receptor: Molecular cloning, genomic organization, and functional expression
47. Cloning and functional characterization of the mouse C3a anaphylatoxin receptor gene
48. Cloning and characterization of rat C3a receptor: Differential expression of rat C3a and C5a receptors by LPS stimulation
49. cDNA cloning and characterization of rat C5a anaphylatoxin receptor
50. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: Alternative splicing in the large extracellular loop
51. Pulmonary injury induced by C3a and C5a anaphylatoxins
52. Recombinant human C5a-induced broncho-constriction in the guinea-pig: A histamine independent mechanism
53. Contraction of guinea pig lung by synthetic oligopeptides related to human C3a
54. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue
55. Synergism between inflammatory mediators in vivo: Induction of airway hyperresponsiveness to C3a in the guinea pig
56. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses
57. Cutting edge: Targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxinshock
58. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
59. Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time
60. Differentiated structure and function of cultures from human tracheal epithelium
61. Structural diversity in the extracellular faces of peptidergic G protein-coupled receptors: Molecular cloning of the mouse C5a anaphylatoxin receptor
62. Detection of mRNA on paraffin embeded material of the central nervous system with DIG-labeled RNA probes
63. The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells
64. C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells
65. A C3a receptor defective guinea pig strain exhibits decreased bronchial reactivity in an ovalbumin-induced asthma model
66. A role for the C3a anaphylatoxin receptor in the effector phase of asthma
67. ELISA of complement C3a in bronchoalveolar lavage fluid
68. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients
69. Complement activation and increased alveolar-capillary permeability after major surgery and in adult respiratory distress syndrome
70. Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for the adult respiratory distress syndrome
71. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome
72. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways
73. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates
74. Mechanisms of enhanced lung injury during sepsis
75. Requirement and role of C5a in acute lung inflammatory injury in rats
76. Minor role of the C3a receptor in systemic anaphylaxis in the guinea pig
77. The C5a chemoattractant receptor mediates mucosal defence to infection